CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
COGENTbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04912089
NCT04912089N/ACompleted
CompareCT.gov

Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol Using Computer-based Training

University of California, San Diego·interventional·Posted Jun 3, 2021·Updated Jul 23, 2025

In Brief

A clinical study evaluating COGENT for Anxiety Disorders and 2 related conditions. Completed, enrolled 73 participants across 1 site.

Detailed Summary

The proposed project aims to test the cognitive and neural effects of a cognitive training in a sample of individuals seeking treatment for anxiety, depression, or traumatic stress symptoms. Participants will be randomly assigned to a high dose, low dose, or assessment only condition. Participants will be compared on cognitive performance and brain response during cognitive tasks from baseline to post-treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety Disorders, Depression, Posttraumatic Stress Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJun 3, 2021
Enrollment StartOct 15, 2021
Primary CompletionMay 31, 2023
Study CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.1 years ago

Interventions

COGENTbehavioral

COGENT is based on a working memory capacity task, which requires individuals to memorize stimuli while simultaneously completing a secondary puzzle task.